, Nature
,
Comparaison des complications entre les deux groupes ,
,
,
,
,
,
,
,
,
,
, REFERENCES BIBLIOGRAPHIQUES 1. Institut National du Cancer. Les cancers en France. édition, pp.202-210, 2015.
Carcinoma of the Ovary, Int. J. Gynecol. Obstet, vol.95, pp.161-192, 2006. ,
, WHO classification of tumours of female reproductive organs. (International Agency for Research on Cancer, 2014.
The Peritoneal Ligaments and Mesenterles: Pathways of Intraabdominal Spread of Disease, Radiology, vol.163, 1987. ,
Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: By the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO), Cancer, vol.115, pp.1234-1244, 2009. ,
Optimal primary surgical treatment for advanced epithelial ovarian cancer, Cochrane Database of Systematic Reviews, 2011. ,
,
, J. Chir, vol.141, pp.277-284, 2004.
, Thérapeutique du cancer, 2011.
Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm, Gynecol. Oncol, vol.114, pp.26-31, 2009. ,
Training in Bowel and Upper Abdominal Surgery in Gynaecological Oncology, European Society of Gynecological Oncology (ESGO) Statement. Int. J. Gynecol. Cancer, vol.1, 2011. ,
Advanced cytoreductive surgery: American perspective, Gynecol. Oncol, vol.114, pp.3-9, 2009. ,
Splenectomy and surgical cytoreduction in epithelial ovarian cancer: a review: Splenectomy for ovarian cancer cytoreduction, Eur. J. Cancer Care (Engl.), vol.20, pp.287-293, 2011. ,
Splenectomy in cytoreductive surgery for advanced ovarian cancer, Arch. Gynecol. Obstet, vol.271, pp.329-331, 2005. ,
The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas, Gynecol. Oncol, vol.119, pp.38-42, 2010. ,
Aggressive Surgical Effort and Improved Survival in Advanced-Stage Ovarian Cancer, Obstet. Gynecol, vol.107, pp.77-85, 2006. ,
Splenectomy in the context of primary cytoreductive operations for advanced epithelial ovarian cancer, Gynecol. Oncol, vol.100, pp.344-348, 2006. ,
Splenectomy as part of cytoreductive surgery in ovarian cancer, Gynecol. Oncol, vol.102, pp.369-374, 2006. ,
Correlation Between Macroscopic and Microscopic Diseases on Splenectomies Performed in the Surgical Management of Ovarian Cancer, Int. J. Gynecol. Cancer, vol.20, pp.965-970, 2010. ,
Chirurgie des cancers gynécologiques, 2014. ,
Risk of Infection and Death Among Postsplenectomy Patients, J. Infect, vol.43, pp.182-186, 2001. ,
,
, Splénectomie dans les tumeurs ovariennes. La Lettre du Gynécologue, vol.354, 2010.
Prévention du risque infectieux postopératoire chez les patients splénectomisés, Ann. Fr. Anesth. Réanimation, vol.24, pp.807-813, 2005. ,
Prevention and management of infections in patients without a spleen, Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis, vol.7, pp.657-660, 2001. ,
Medical complications following splenectomy, J. Visc. Surg, vol.153, pp.277-286, 2016. ,
Risk of venous thromboembolism in splenectomized patients compared with the general population and appendectomized patients: a 10-year nationwide cohort study: Letters to the Editor, J. Thromb. Haemost, vol.8, pp.1413-1416, 2010. ,
Splenectomy is associated with a higher risk for venous thromboembolism: A prospective cohort study, Int. J. Surg, vol.24, pp.27-32, 2015. ,
Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis, J. Clin. Oncol, vol.20, pp.1248-1259, 2002. ,
Management of Pancreatic Fistulas After a Splenectomy as Part of Cytoreductive Surgery for Ovarian Cancer, Int. J. Gynecol. Cancer, vol.23, pp.1506-1511, 2013. ,
Distal pancreatectomy with splenectomy for the management of splenic hilum metastasis in cytoreductive surgery of epithelial ovarian cancer, J. Gynecol. Oncol, vol.27, 2016. ,
Upper abdominal surgical procedures: Liver mobilization and diaphragm peritonectomy/resection, splenectomy, and distal pancreatectomy ,
, Gynecol. Oncol, vol.111, pp.51-55, 2008.
Splenectomy in gynecologic oncology: indications, complications, and technique, Gynecol. Oncol, vol.43, pp.118-122, 1991. ,
Staging classification for cancer of the ovary, fallopian tube, and peritoneum, Int. J. Gynecol. Obstet, vol.124, pp.1-5, 2014. ,
The Clavien-Dindo Classification of Surgical Complications: FiveYear Experience, Ann. Surg, vol.250, pp.187-196, 2009. ,
Chemotherapy delay after primary debulking surgery for ovarian cancer, Gynecol. Oncol, vol.144, pp.260-265, 2017. ,
Relationship between initiation time of adjuvant chemotherapy and survival in ovarian cancer patients: a dose-response meta-analysis of cohort studies, Sci. Rep, vol.7, 2017. ,
Comparative Evaluation of Diagnostic Methods in Ovarian Carcinoma with Emphasis on CT and MRI, Gynecol. Oncol, vol.52, pp.191-198, 1994. ,
Comparative study of tumor evaluation with computerized tomography and surgery in ovarian cancer ,
, J. Radiol, vol.79, pp.27-32, 1998.
Les critères qualité pour la chirurgie du cancer de l'ovaire. mesure 21-3, plan cancer, pp.383-433, 2009. ,
Effect of Surgeon Specialty on Processes of Care and Outcomes for Ovarian Cancer Patients, JNCI J. Natl. Cancer Inst, vol.98, pp.172-180, 2006. ,
Quality of care in advanced ovarian cancer: The importance of provider specialty, Gynecol. Oncol, vol.117, pp.18-22, 2010. ,
The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: A systematic review, Gynecol. Oncol, vol.105, pp.801-812, 2007. ,
Splenectomy as Part of Cytoreductive Surgery for Ovarian Carcinoma ,
, Gynecol. Oncol, vol.58, pp.244-247, 1995.
Parenchymal splenic metastasis is an independent negative predictor of overall survival in advanced ovarian, fallopian tube, and primary peritoneal cancer, Gynecol. Oncol, vol.128, pp.28-33, 2013. ,
Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis, Am. J. Physiol.-Cell Physiol, vol.309, pp.444-456, 2015. ,
Splenectomy as Part of Primary Cytoreductive Surgery for Advanced Ovarian Cancer: A Retrospective Cohort Study, Int. J. Gynecol. Cancer, vol.22, pp.968-973, 2012. ,
Prognostic Significance of Splenectomy as Part of Initial Cytoreductive Surgery in Ovarian Cancer, Ann. Surg. Oncol, vol.18, pp.2912-2918, 2011. ,
Multiple large bowel resections: Potential risk factor for anastomotic leak, Gynecol. Oncol, vol.130, pp.213-218, 2013. ,
Surgical Complications Are Associated With Omission of Chemotherapy for Stage III Colorectal Cancer, Dis. Colon Rectum, vol.53, pp.1587-1593, 2010. ,
Variability in chemotherapy delivery for elderly women with advanced stage ovarian cancer and its impact on survival, Br. J. Cancer, vol.98, pp.1197-1203, 2008. ,
Hematogenous Splenic Metastases as an Independent Negative Prognosis Factor at the Moment of Primary Cytoreduction in Advanced Stage Epithelial Ovarian Cancer-A Single Center Experience, Anticancer Research October, vol.35, pp.5649-5654, 2015. ,
Indocyanine green loaded hyaluronan-derived nanoparticles for fluorescenceenhanced surgical imaging of pancreatic cancer, Nanomedicine Nanotechnol. Biol. Med, vol.14, pp.769-780, 2018. ,
A Novel Tumor-Specific Agent for Intraoperative Near-Infrared Fluorescence Imaging: A Translational Study in Healthy Volunteers and Patients with Ovarian Cancer, Clin. Cancer Res, vol.22, pp.2929-2938, 2016. ,
Improved Debulking of Peritoneal Tumor Implants by Near-Infrared Fluorescent Nanobody Image Guidance in an Experimental Mouse Model, Mol. Imaging Biol, vol.20, pp.361-367, 2018. ,
HEPATOFLUO: A prospective monocentric study assessing the benefits of indocyanine green (ICG) fluorescence for hepatic surgery, J. Surg. Oncol, vol.117, pp.922-927, 2018. ,
Indocyanine Green Fluorescence Imaging-Guided Surgery in Primary and Metastatic Liver Tumors, Surg. Innov, vol.25, pp.62-68, 2018. ,
, ANNEXES Annexe 1 classification TNM (7° édition) et stades FIGO, 2013.
, Notes : * stade IC 1 : rupture chirurgicale, stade IC 2 : rupture pré-op ou cellules tumorales à la surface de l'ovaire ou la trompe, stade IC 3 : cellules tumorales dans le liquide de lavage péritonéal
, IIIA 1 : atteinte ganglionnaire isolée, stade IIIA 2 : atteinte microscopique abdominale +/-ganglionnaire
, épanchement pleural avec cytologie positive, stade IV b : métastase parenchymateuse ou extra-abdominale
, Notes : exemples extraits du tableau 2 de l'article de Dindo et al « Classification of Surgical Complications, A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey, Ann. Surg, pp.205-213, 2004.